{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T01:11:23Z","timestamp":1779930683934,"version":"3.53.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Western-Eastern European Partnership Initiative on HIV, viral hepatitis and tuberculosis","award":["201"],"award-info":[{"award-number":["201"]}]},{"name":"The Western-Eastern European Partnership Initiative on HIV, viral hepatitis and tuberculosis","award":["201"],"award-info":[{"award-number":["201"]}]},{"name":"The Western-Eastern European Partnership Initiative on HIV, viral hepatitis and tuberculosis","award":["201"],"award-info":[{"award-number":["201"]}]},{"name":"Cooperatio Programme, the HEAS research area"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"DOI":"10.1186\/s12954-025-01246-4","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T14:24:00Z","timestamp":1749738240000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Informed implementation practice \u2013 formative research of a mobile drug consumption room in Brno, Czech Republic"],"prefix":"10.1186","volume":"22","author":[{"given":"Viktor","family":"Mrav\u010d\u00edk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Jan\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danica","family":"Thanki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Nov\u00e1kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Matou\u0161ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Ps\u00e1rska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Matu\u0161\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u017dofie","family":"Buchalov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"Dospiviov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Ma\u0161kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Bla\u017eek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"key":"1246_CR1","unstructured":"EMCDDA, C-EHRN. Joint report by the EMCDDA and C-EHRN: Drug consumption rooms. Lisbon: European Monitoring Centre for Drugs and Drug Addiction and Correlation \u2013 European Harm Reduction Network; 2023"},{"issue":"6","key":"1246_CR2","first-page":"503","volume":"15","author":"D Hedrich","year":"2008","unstructured":"Hedrich D, Pirona A, Wiessing L. From margin to mainstream: the evolution of harm reduction responses to problem drug use in Europe. Drugs: Educ Prev Policy. 2008;15(6):503\u201317.","journal-title":"Drugs: Educ Prev Policy"},{"key":"1246_CR3","unstructured":"Rhodes T, Hedrich D. Harm reduction and the mainstream. In: Rhodes T, Hedrich D, editors. Harm reduction: evidence, impacts and challenges Scientific Monograph Series No 10. Lisbon: European monitoring centre for drugs and drug addiction; 2010"},{"key":"1246_CR4","unstructured":"EMCDDA. Spotlight on Drug consumption rooms Lisbon: European Monitoring Centre for Drugs and Drug Addiction; 2022. Available from: https:\/\/www.euda.europa.eu\/spotlights\/drug-consumption-rooms_en"},{"key":"1246_CR5","unstructured":"EMCDDA. Prevence smrteln\u00fdch p\u0159ed\u00e1vkov\u00e1n\u00ed. Zaost\u0159eno. 2019;2019(1):1\u20138"},{"key":"1246_CR6","unstructured":"ECDC, EMCDDA. Prevention and control of infectious diseases among people who inject drugs: 2023 update. Stockholm: ECDC; 2023 2011"},{"issue":"2","key":"1246_CR7","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1093\/ije\/dyac120","volume":"52","author":"P Roux","year":"2023","unstructured":"Roux P, Jauffret-Roustide M, Donadille C, Briand Madrid L, Denis C, C\u00e9l\u00e9rier I, et al. Impact of drug consumption rooms on non-fatal overdoses, abscesses and emergency department visits in people who inject drugs in France: results from the COSINUS cohort. Int J Epidemiol. 2023;52(2):562\u201376.","journal-title":"Int J Epidemiol"},{"issue":"5","key":"1246_CR8","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.amepre.2021.04.017","volume":"61","author":"TW Levengood","year":"2021","unstructured":"Levengood TW, Yoon GH, Davoust MJ, Ogden SN, Marshall BDL, Cahill SR, et al. Supervised injection facilities as harm reduction: a systematic review. Am J Prev Med. 2021;61(5):738\u201349.","journal-title":"Am J Prev Med"},{"issue":"1","key":"1246_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.drugpo.2013.07.001","volume":"25","author":"GJ MacArthur","year":"2014","unstructured":"MacArthur GJ, van Velzen E, Palmateer N, Kimber J, Pharris A, Hope V, et al. Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness. Int J Drug Policy. 2014;25(1):34\u201352.","journal-title":"Int J Drug Policy"},{"key":"1246_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.drugalcdep.2014.10.012","volume":"145","author":"C Potier","year":"2014","unstructured":"Potier C, Lapr\u00e9vote V, Dubois-Arber F, Cottencin O, Rolland B. Supervised injection services: what has been demonstrated? A systematic literature review. Drug Alcohol Depend. 2014;145:48\u201368.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"1246_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1177\/0022042617727513","volume":"48","author":"AJ Myer","year":"2017","unstructured":"Myer AJ, Belisle L. Highs and lows: an interrupted time-series evaluation of the impact of north America\u2019s only supervised injection facility on crime. J Drug Issues. 2017;48(1):36\u201349.","journal-title":"J Drug Issues"},{"key":"1246_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1747-597X-1-13","volume":"1","author":"E Wood","year":"2006","unstructured":"Wood E, Tyndall MW, Lai C, Montaner JSG, Kerr T. Impact of a medically supervised safer injecting facility on drug dealing and other drug-related crime. Subst Abus Treat Prev Policy. 2006;1:13.","journal-title":"Subst Abus Treat Prev Policy"},{"key":"1246_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.drugpo.2018.09.008","volume":"62","author":"C Folch","year":"2018","unstructured":"Folch C, Lorente N, Maj\u00f3 X, Par\u00e9s-Badell O, Roca X, Brugal T, et al. Drug consumption rooms in Catalonia: a comprehensive evaluation of social, health and harm reduction benefits. Int J Drug Policy. 2018;62:24\u20139.","journal-title":"Int J Drug Policy"},{"key":"1246_CR14","unstructured":"Hedrich D, Kerr T, Dubois-Arber F. Drug consumption facilities in Europe and beyond. In: Rhodes T, Hedrich D, editors. Harm reduction: evidence, impacts and challenges. EMCDDA Scientific Monograph Series. Lisbon: European monitoring centre for drugs and drug addiction; 2010. p. 305\u201331"},{"key":"1246_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jsat.2019.08.010","volume":"106","author":"CN Behrends","year":"2019","unstructured":"Behrends CN, Paone D, Nolan ML, Tuazon E, Murphy SM, Kapadia SN, et al. Estimated impact of supervised injection facilities on overdose fatalities and healthcare costs in New York City. J Subst Abuse Treat. 2019;106:79\u201388.","journal-title":"J Subst Abuse Treat"},{"issue":"Suppl 1","key":"1246_CR16","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.drugpo.2014.11.007","volume":"26","author":"DP Wilson","year":"2015","unstructured":"Wilson DP, Donald B, Shattock AJ, Wilson D, Fraser-Hurt N. The cost-effectiveness of harm reduction. Int J Drug Policy. 2015;26(Suppl 1):S5-11.","journal-title":"Int J Drug Policy"},{"issue":"3","key":"1246_CR17","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/add.13195","volume":"111","author":"EA Enns","year":"2016","unstructured":"Enns EA, Zaric GS, Strike CJ, Jairam JA, Kolla G, Bayoumi AM. Potential cost-effectiveness of supervised injection facilities in Toronto and Ottawa. Canada Addiction. 2016;111(3):475\u201389.","journal-title":"Canada Addiction"},{"key":"1246_CR18","unstructured":"EMCDDA. Infographic. Location and number of drug consumption facilities throughout Europe Lisbon: European Union Drugs Agency; 2023 [Available from: https:\/\/www.euda.europa.eu\/media-library\/infographic-location-and-number-drug-consumption-room-facilities-throughout-europe_en"},{"key":"1246_CR19","unstructured":"ENDCR. Location and number of drug consumption rooms throughout Europe. Amsterdam: Correlation \u2013 European Harm Reduction Network; 2024"},{"key":"1246_CR20","volume-title":"Global state of harm reduction 2022","author":"Harm Reduction International","year":"2022","unstructured":"Harm Reduction International. Global state of harm reduction 2022. London: Harm Reduction International; 2022."},{"issue":"1","key":"1246_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/1478601X.2023.2275795","volume":"37","author":"R Ricciardelli","year":"2024","unstructured":"Ricciardelli R, Whitten C, Johnston M. \u201cHow are we gonna get them off the drugs if they\u2019re allowed to stay on it?\u201d correctional officer perspectives on Overdose prevention sites in prisons. Crim Justice Stud. 2024;37(1):39\u201358.","journal-title":"Crim Justice Stud"},{"key":"1246_CR22","doi-asserted-by":"publisher","first-page":"103131","DOI":"10.1016\/j.drugpo.2021.103131","volume":"92","author":"L McKendy","year":"2021","unstructured":"McKendy L, Biro SM, Miron M, Keown LA. Understanding overdose incidents in Canadian federal custody. Int J Drug Policy. 2021;92:103131.","journal-title":"Int J Drug Policy"},{"key":"1246_CR23","unstructured":"Moura J, Darragh L, Perez Gayo R, Jeziorska I, Schiffer K. Drug consumption rooms in Europe \u2013 operational overview. Amsterdam: correlation \u2013 European harm reduction network; 2023"},{"key":"1246_CR24","unstructured":"Z\u00e1bransk\u00fd T. Aplika\u010dn\u00ed a u\u017eivatelsk\u00e9 m\u00edstnosti: p\u0159ehled dostupn\u00fdch zku\u0161enost\u00ed a v\u00fdzkumu [Application and User Rooms: an Overview of Available Experiences and Research]. Praha: M\u011bstsk\u00e1 \u010d\u00e1st Praha 1; 1999. p. 20"},{"key":"1246_CR25","first-page":"252","volume":"4","author":"K Mlad\u00e1","year":"2010","unstructured":"Mlad\u00e1 K, Pavlovsk\u00e1 A, Nov\u00e1k P. Vybran\u00e9 harm reduction slu\u017eby v Berl\u00edn\u011b. Adiktologie. 2010;4:252\u20138.","journal-title":"Adiktologie"},{"key":"1246_CR26","unstructured":"Z\u00e1bransk\u00fd T. Aplika\u010dn\u00ed m\u00edstnosti, nebo \u0161leh\u00e1rny? Praha: Listy Prahy 1 a Neviditeln\u00fd pes; 2001. Available from: https:\/\/www.minarcik.cz\/noviny\/aplikacni.htm"},{"key":"1246_CR27","unstructured":"Proch\u00e1zkov\u00e1 L, Herzog A. Kauza o V\u00e1clav\u00e1k aneb p\u0159\u00edpadov\u00e1 studie monitoruj\u00edc\u00ed aktivity sm\u011b\u0159uj\u00edc\u00ed k \u0159e\u0161en\u00ed situace v\u00fdskytu otev\u0159en\u00e9 drogov\u00e9 sc\u00e9ny na V\u00e1clavsk\u00e9m n\u00e1m\u011bst\u00ed v Praze. 2010"},{"issue":"1","key":"1246_CR28","first-page":"1","volume":"9","author":"B Jan\u00edkov\u00e1","year":"2011","unstructured":"Jan\u00edkov\u00e1 B. Aplika\u010dn\u00ed m\u00edstnosti \u2013 centra pro zdravotnicky supervidovanou aplikaci omamn\u00fdch a psychotropn\u00edch l\u00e1tek. Zaost\u0159eno na drogy. 2011;9(1):1\u201311.","journal-title":"Zaost\u0159eno na drogy"},{"key":"1246_CR29","volume-title":"Z\u0159izov\u00e1n\u00ed a provozov\u00e1n\u00ed aplika\u010dn\u00edch m\u00edstnost\u00ed pro u\u017eivatele drog: p\u0159ehled zahrani\u010dn\u00edch zku\u0161enost\u00ed","author":"R Reme\u0161ov\u00e1","year":"2017","unstructured":"Reme\u0161ov\u00e1 R. Z\u0159izov\u00e1n\u00ed a provozov\u00e1n\u00ed aplika\u010dn\u00edch m\u00edstnost\u00ed pro u\u017eivatele drog: p\u0159ehled zahrani\u010dn\u00edch zku\u0161enost\u00ed. Praha: Univerzita Karlova; 2017."},{"key":"1246_CR30","volume-title":"Aplika\u010dn\u00ed m\u00edstnosti pro u\u017eivatele drog - anal\u00fdza pot\u0159eb","author":"V Janou\u0161kovec","year":"2013","unstructured":"Janou\u0161kovec V. Aplika\u010dn\u00ed m\u00edstnosti pro u\u017eivatele drog - anal\u00fdza pot\u0159eb. Praha: Univerzita Karlova; 2013."},{"key":"1246_CR31","volume-title":"Ne\/zaveden\u00ed aplika\u010dn\u00edch m\u00edstnost\u00ed v \u010cesk\u00e9 republice","author":"M Moravcov\u00e1","year":"2014","unstructured":"Moravcov\u00e1 M. Ne\/zaveden\u00ed aplika\u010dn\u00edch m\u00edstnost\u00ed v \u010cesk\u00e9 republice. Praha: Univerzita Karlova; 2014."},{"key":"1246_CR32","unstructured":"Mrav\u010d\u00edk V. Mobiln\u00ed aplika\u010dn\u00ed m\u00edstnost v Brn\u011b - prezentace. Semin\u00e1\u0159 o aplika\u010dn\u00ed m\u00edstnosti v Brn\u011b; 29. \u010dervna 2023; Podan\u00e1 kav\u00e1rna, Brno: Spole\u010dnost Podan\u00e9 ruce; 2023"},{"key":"1246_CR33","unstructured":"Spole\u010dnost Podan\u00e9 ruce. Spole\u010dnost Podan\u00e9 ruce spou\u0161t\u00ed v Brn\u011b prvn\u00ed program bezpe\u010dn\u011bj\u0161\u00ed aplikace a prevence p\u0159ed\u00e1vkov\u00e1n\u00ed v \u010cesk\u00e9 republice Brno: Spole\u010dnost Podan\u00e9 ruce; 2023 [Available from: https:\/\/podaneruce.cz\/spolecnost-podane-ruce-spousti-v-brne-prvni-program-bezpecnejsi-aplikace-a-prevence-predavkovani-v-ceske-republice\/"},{"key":"1246_CR34","unstructured":"Spole\u010dnost Podan\u00e9 ruce. Program aplika\u010dn\u00ed m\u00edstnosti v Brn\u011b a jeho v\u00fdchodiska. Brno: Spole\u010dnost Podan\u00e9 ruce; 2023"},{"key":"1246_CR35","unstructured":"Mrav\u010d\u00edk V, Jan\u00edkov\u00e1 B. Nastaven\u00ed programu a hodnocen\u00ed v\u00fdsledk\u016f Mobiln\u00ed aplika\u010dn\u00ed m\u00edstnosti v Brn\u011b - protokol projektu. Brno: Spole\u010dnost Podan\u00e9 ruce; 2023"},{"key":"1246_CR36","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/09595239996464","volume":"18","author":"G Stimson","year":"2009","unstructured":"Stimson G, Fitch C, Rhodes T, Ball A. Rapid assessment and response: methods for developing public health responses to drug problems. Drug Alcohol Rev. 2009;18:317\u201325.","journal-title":"Drug Alcohol Rev"},{"key":"1246_CR37","unstructured":"Mounteney J, Atkin-Brenninkmeyer E, Ruiz MJ, Bo A, Matias J, Jekabsone I, et al. Trendspotter manual: a handbook for the rapid assessment of emerging drug-related trends 2018"},{"key":"1246_CR38","unstructured":"Nepustil P, P\u0159ibylov\u00e1 P, Vesel\u00fd O, Vrbov\u00e1 K. Zpr\u00e1va o situaci v oblasti drog a z\u00e1vislost\u00ed v Brn\u011b za rok 2021. Brno: Magistr\u00e1t m\u011bsta Brna, obor soci\u00e1ln\u00ed p\u00e9\u010de, Koordina\u010dn\u00ed centrum prevence; 2022"},{"key":"1246_CR39","unstructured":"AdRes Institut. RDS studie \u2013 seroprevalen\u010dn\u00ed studie a odhad probl\u00e9mov\u00e9ho u\u017e\u00edv\u00e1n\u00ed drog ve statut\u00e1rn\u00edm m\u011bst\u011b Brn\u011b. Z\u00e1v\u011bre\u010dn\u00e1 zpr\u00e1va. Brno: Magistr\u00e1t m\u011bsta Brna; 2019"},{"key":"1246_CR40","unstructured":"Fanfrlov\u00e1 M, Nepustil P, Vesel\u00fd O, Vrbov\u00e1 K. Zpr\u00e1va o situaci v oblasti drog a z\u00e1vislost\u00ed v Brn\u011b za rok 2022. Brno: Magistr\u00e1t m\u011bsta Brna, obor soci\u00e1ln\u00ed p\u00e9\u010de, Koordina\u010dn\u00ed centrum prevence; 2023"},{"key":"1246_CR41","unstructured":"Spole\u010dnost Podan\u00e9 ruce. V\u00fdro\u010dn\u00ed zpr\u00e1va 2022. Brno: Spole\u010dnost Podan\u00e9 ruce o.p.s.; 2023"},{"issue":"2","key":"1246_CR42","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.drugpo.2010.12.001","volume":"22","author":"V Mrav\u010d\u00edk","year":"2011","unstructured":"Mrav\u010d\u00edk V, \u0160ka\u0159upov\u00e1 K, Orl\u00edkov\u00e1 B, Z\u00e1bransk\u00fd T, Karachaliou K, Schulte B. Use of gelatine capsules for application of methamphetamine: a new harm reduction approach. Int J Drug Policy. 2011;22(2):172\u20133.","journal-title":"Int J Drug Policy"},{"key":"1246_CR43","volume-title":"Aplika\u010dn\u00ed m\u00edstnost jako sou\u010d\u00e1st harm reduction slu\u017eeb: diplomov\u00e9 pr\u00e1ce","author":"J Kopic","year":"2017","unstructured":"Kopic J. Aplika\u010dn\u00ed m\u00edstnost jako sou\u010d\u00e1st harm reduction slu\u017eeb: diplomov\u00e9 pr\u00e1ce. Brno: Masarykova Univerzita; 2017."},{"key":"1246_CR44","unstructured":"Miovsk\u00e1 L, Miovsk\u00fd M, Gabrhel\u00edk R, Charv\u00e1t M. Anal\u00fdza pot\u0159eb klient\u016f n\u00edzkoprahov\u00fdch za\u0159\u00edzen\u00ed. Praha: \u00da\u0159ad vl\u00e1dy \u010cR; 2005"},{"key":"1246_CR45","volume-title":"European report on drug consumption rooms","author":"D Hedrich","year":"2004","unstructured":"Hedrich D. European report on drug consumption rooms. Lisbon: European monitoring centre for drugs and drug addiction; 2004."},{"issue":"1","key":"1246_CR46","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12954-022-00665-x","volume":"19","author":"E Duncan","year":"2022","unstructured":"Duncan E, Shufelt S, Barranco M, Udo T. Acceptability of supervised injection facilities among persons who inject drugs in upstate New York. Harm Reduct J. 2022;19(1):87.","journal-title":"Harm Reduct J"},{"issue":"5","key":"1246_CR47","doi-asserted-by":"publisher","first-page":"e226","DOI":"10.1097\/ADM.0000000000000646","volume":"14","author":"S Ickowicz","year":"2020","unstructured":"Ickowicz S, Grant C, Nosova E, Boyd J, Brar R, Milloy MJ, et al. Factors associated with the use of supervised consumption facilities among women who inject drugs in a Canadian setting. J Addctn Med. 2020;14(5):e226\u201332.","journal-title":"J Addctn Med"},{"key":"1246_CR48","doi-asserted-by":"publisher","first-page":"108042","DOI":"10.1016\/j.drugalcdep.2020.108042","volume":"212","author":"S Rouhani","year":"2020","unstructured":"Rouhani S, White RH, Park JN, Sherman SG. High willingness to use overdose prevention sites among female sex workers in Baltimore. Md Drug Alcohol Depend. 2020;212:108042.","journal-title":"Md Drug Alcohol Depend"},{"key":"1246_CR49","doi-asserted-by":"publisher","first-page":"102731","DOI":"10.1016\/j.drugpo.2020.102731","volume":"90","author":"KMA Trayner","year":"2021","unstructured":"Trayner KMA, Palmateer NE, Hutchinson SJ, Goldberg DJ, Shepherd SJ, Gunson RN, et al. High willingness to use drug consumption rooms among people who inject drugs in Scotland: findings from a national bio-behavioural survey among people who inject drugs. Int J Drug Policy. 2021;90:102731.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1246_CR50","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12954-023-00887-7","volume":"20","author":"M Chappuy","year":"2023","unstructured":"Chappuy M, Lack P, David B, Penavayre G, Thabourey D, Landulpho M, et al. Willingness to use a drug consumption room among people who use drugs in Lyon, France, a city with no open scene of drug use (the TRABOUL survey). Harm Reduct J. 2023;20(1):149.","journal-title":"Harm Reduct J"},{"issue":"1","key":"1246_CR51","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/08897077.2017.1365804","volume":"39","author":"C Le\u00f3n","year":"2018","unstructured":"Le\u00f3n C, Cardoso L, Mackin S, Bock B, Gaeta JM. The willingness of people who inject drugs in Boston to use a supervised injection facility. Subst Abus: Off Publ Assoc Med Educ Res Subst Abus. 2018;39(1):95\u2013101.","journal-title":"Subst Abus: Off Publ Assoc Med Educ Res Subst Abus"},{"issue":"1","key":"1246_CR52","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/ajad.13065","volume":"30","author":"SR Kenney","year":"2021","unstructured":"Kenney SR, Anderson BJ, Bailey GL, Herman DS, Conti MT, Stein MD. Examining overdose and homelessness as predictors of willingness to use supervised injection facilities by services provided among persons who inject drugs. Am J Addict. 2021;30(1):21\u20135.","journal-title":"Am J Addict"},{"key":"1246_CR53","doi-asserted-by":"crossref","unstructured":"Chomynov\u00e1 P, Koz\u00e1k J, Mrav\u010d\u00edk V. Substance use in Roma population in contact with social workers in the Czech Republic: A cross-sectional questionnaire survey. Journal of ethnicity in substance abuse. 2020:1\u201320","DOI":"10.1080\/15332640.2020.1717399"},{"issue":"1","key":"1246_CR54","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12954-019-0319-1","volume":"16","author":"H Taylor","year":"2019","unstructured":"Taylor H, Curado A, Tavares J, Oliveira M, Gautier D, Maria JS. Prospective client survey and participatory process ahead of opening a mobile drug consumption room in Lisbon. Harm Reduct J. 2019;16(1):49.","journal-title":"Harm Reduct J"},{"key":"1246_CR55","doi-asserted-by":"publisher","unstructured":"Woods S. Drug Consumption Rooms in Europe - organisational overview. Researchgate: 2014. https:\/\/doi.org\/10.13140\/RG.2.2.34829.15842","DOI":"10.13140\/RG.2.2.34829.15842"},{"issue":"1","key":"1246_CR56","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3109\/00952990.2011.600389","volume":"38","author":"K DeBeck","year":"2012","unstructured":"DeBeck K, Kerr T, Lai C, Buxton J, Montaner J, Wood E. The validity of reporting willingness to use a supervised injecting facility on subsequent program use among people who use injection drugs. Am J Drug Alcohol Abuse. 2012;38(1):55\u201362.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"5","key":"1246_CR57","first-page":"256","volume":"12","author":"M Danosov\u00e1","year":"2015","unstructured":"Danosov\u00e1 M, Mach\u00e1lkov\u00e1 L, Mazalov\u00e1 L, Buben\u00edkov\u00e1 \u0160, Pastucha D. Vn\u00edm\u00e1n\u00ed zdrav\u00ed u romsk\u00e9ho etnika. Med praxi. 2015;12(5):256\u20139.","journal-title":"Med praxi"},{"issue":"2","key":"1246_CR58","first-page":"98","volume":"2","author":"A Herzog","year":"2019","unstructured":"Herzog A, Kocian M, Pla\u010dek J. Zmen\u0161ov\u00e1n\u00ed drogov\u00e9ho trhu v centru Prahy. Adiktol prevent l\u00e9\u010deb praxi. 2019;2(2):98\u2013105.","journal-title":"Adiktol prevent l\u00e9\u010deb praxi"},{"key":"1246_CR59","volume-title":"Zpr\u00e1va o neleg\u00e1ln\u00edch drog\u00e1ch v \u010cesk\u00e9 republice 2021","author":"V Mrav\u010d\u00edk","year":"2021","unstructured":"Mrav\u010d\u00edk V, Chomynov\u00e1 P, Grohmannov\u00e1 K, Jan\u00edkov\u00e1 B, \u010cern\u00edkov\u00e1 T, Rous Z, et al. Zpr\u00e1va o neleg\u00e1ln\u00edch drog\u00e1ch v \u010cesk\u00e9 republice 2021. Praha: \u00da\u0159ad vl\u00e1dy \u010cesk\u00e9 republiky; 2021."},{"key":"1246_CR60","unstructured":"Mrav\u010d\u00edk V, Va\u0159ekov\u00e1 Z, Jan\u00edkov\u00e1 B. Destigmatizace u\u017e\u00edv\u00e1n\u00ed psychoaktivn\u00edch l\u00e1tek a adiktologick\u00fdch slu\u017eeb. Strategick\u00fd souhrn a doporu\u010den\u00ed pro drogovou politiku. Praha: Spole\u010dnost Podan\u00e9 ruce a Hlavn\u00ed m\u011bsto Praha; 2022"},{"key":"1246_CR61","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.drugpo.2018.04.014","volume":"56","author":"M Jauffret-Roustide","year":"2018","unstructured":"Jauffret-Roustide M, Cailbault I. Drug consumption rooms: comparing times, spaces and actors in issues of social acceptability in French public debate. Int J Drug Policy. 2018;56:208\u201317.","journal-title":"Int J Drug Policy"},{"issue":"S2","key":"1246_CR62","doi-asserted-by":"publisher","first-page":"S159","DOI":"10.2105\/AJPH.2022.306808","volume":"112","author":"E Houborg","year":"2022","unstructured":"Houborg E, Jauffret-Roustide M. Drug consumption rooms: welfare state and diversity in social acceptance in Denmark and in France. Am J Public Health. 2022;112(S2):S159\u201365.","journal-title":"Am J Public Health"},{"issue":"S2","key":"1246_CR63","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.2105\/AJPH.2022.306790","volume":"112","author":"M Jauffret-Roustide","year":"2022","unstructured":"Jauffret-Roustide M, Houborg E, Southwell M, Chronopoulou D, Granier JM, Frank VA, et al. Different paths and potentials to harm reduction in different welfare states: drug consumption rooms in the United Kingdom, Denmark, and France. Am J Public Health. 2022;112(S2):S99-s103.","journal-title":"Am J Public Health"},{"issue":"6","key":"1246_CR64","first-page":"231","volume":"162","author":"V Mrav\u010d\u00edk","year":"2023","unstructured":"Mrav\u010d\u00edk V. Dekriminalizace a chytr\u00e1 regulace psychoaktivn\u00edch l\u00e1tek \u2013 modern\u00ed alternativa prohibice [Decriminalisation and smart regulation of psychoactive substances: a modern alternative to prohibition]. \u010cas L\u00e9k \u010des. 2023;162(6):231\u20137.","journal-title":"\u010cas L\u00e9k \u010des"},{"issue":"2","key":"1246_CR65","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1016\/S2215-0366(15)00008-5","volume":"2","author":"M Malliori","year":"2015","unstructured":"Malliori M, Galinaki S, Papakonstantinou AK. ODYSSEAS: supervised use of drugs versus bureaucracy in Greece. Lancet Psychiatry. 2015;2(2):e3.","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"1246_CR66","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/09687630500412239","volume":"13","author":"A Skretting","year":"2006","unstructured":"Skretting A. The Nordic countries and public drug-injection facilities. Drugs Educ Prevent Policy. 2006;13(1):5\u201316.","journal-title":"Drugs Educ Prevent Policy"},{"key":"1246_CR67","unstructured":"Jel\u00ednek J. Trestn\u00ed z\u00e1kon\u00edk a trestn\u00ed \u0159\u00e1d s pozn\u00e1mkami a judikaturou. Praha: Leges; 2014"},{"key":"1246_CR68","unstructured":"\u0160\u010derba F. Trestn\u00ed z\u00e1kon\u00edk: koment\u00e1\u0159. Praha: C.H. Beck; 2020"},{"key":"1246_CR69","unstructured":"Mrav\u010d\u00edk V, Jan\u00edkov\u00e1 B, \u010cern\u00edkov\u00e1 T. Koncept aplika\u010dn\u00ed m\u00edstnosti v podm\u00ednk\u00e1ch \u010cR. Praha: \u00da\u0159ad vl\u00e1dy \u010cR, Sekretari\u00e1t Rady vl\u00e1dy pro koordinaci politiky v oblasti z\u00e1vislost\u00ed; 2022"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01246-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-025-01246-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01246-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T19:03:13Z","timestamp":1749754993000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-025-01246-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1246"],"URL":"https:\/\/doi.org\/10.1186\/s12954-025-01246-4","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,12]]},"assertion":[{"value":"15 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research protocol was reviewed by the Ethical Board of the National Monitoring Centre for Drugs and Addictions on 21 July 2023. An approval was issued on 27 July 2023 under reference number EKNMS-3\/2023.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"106"}}